4.7 Article

Oral lactate slows gastric emptying and suppresses appetite in young males

期刊

CLINICAL NUTRITION
卷 41, 期 2, 页码 517-525

出版社

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.clnu.2021.12.032

关键词

GLP-1; Ghrelin; GDF-15; GIP

资金

  1. Aase and Ejnar Danielsens foundation [20-10-0162]
  2. Novo Nordisk Foundation

向作者/读者索取更多资源

Oral lactate administration can directly affect the upper gastrointestinal tract, altering gut hormone secretion, motility, and appetite sensations, which cannot be solely mediated by lactate in the systemic circulation. This may have implications for the treatment of metabolic diseases.
Background: Lactate serves as an alternative energy fuel but is also an important signaling metabolite. We aimed to investigate whether oral lactate administration affects appetite-regulating hormones, slows gastric emptying rate, and dampens appetite. Methods: Ten healthy male volunteers were investigated on two separate occasions: 1) following oral ingestion of D/L-Na-lactate and 2) following oral ingestion of isotonic iso-voluminous NaCl and intravenous iso-lactemic D/L-Na-lactate infusions. Appetite was evaluated by questionnaires and ad libitum meal tests were performed at the end of each study day. Gastric emptying rate was evaluated using the acetaminophen test. Results: Plasma concentrations of growth differential factor 15 (GDF15, primary outcome) increased following oral and iv administration of lactate (p < 0.001) with no detectable difference between interventions (p = 0.15). Oral lactate administration lowered plasma concentrations of acylated ghrelin (p = 0.02) and elevated glucagon like peptide-1 (GLP-1, p = 0.045), insulin (p < 0.001), and glucagon (p < 0.001) compared with iv administration. Oral lactate administration slowed gastric emptying (p < 0.001), increased the feeling of being full (p = 0.008) and lowered the anticipated future food intake (p = 0.007) compared with iv administration. Food intake during the ad libitum meal test did not differ between the two study days. Conclusion: Oral lactate administration has a direct effect on the upper gastrointestinal tract, affecting gut hormone secretion, motility and appetite sensations which cannot be mediated through lactate in the systemic circulation alone. These data suggest that compounds rich in lactate may be useful in the treatment of metabolic disease. Clinical trial registry number: NCT0429981, https://clinicaltrials.gov/ct2/show/NCT04299815. (c) 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据